JANE STREET GROUP, LLC - HEPION PHARMACEUTICALS INC ownership

HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 35 filers reported holding HEPION PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of HEPION PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$23,000
-23.3%
40,445
+72.7%
0.00%
Q1 2022$30,000
-43.4%
23,421
-50.1%
0.00%
Q4 2021$53,000
+47.2%
46,899
+155.9%
0.00%
Q2 2021$36,000
+56.5%
18,328
+45.1%
0.00%
Q1 2021$23,00012,6310.00%
Other shareholders
HEPION PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
PVG ASSET MANAGEMENT CORP 100,089$114,101,0000.42%
Ikarian Capital, LLC 553,273$630,0000.09%
Aristides Capital LLC 49,496$56,0000.03%
McAdam, LLC 62,168$71,0000.01%
Virtu Financial LLC 49,959$57,0000.01%
SABBY MANAGEMENT, LLC 20,479$23,0000.00%
GSA CAPITAL PARTNERS LLP 20,556$23,0000.00%
JGP Wealth Management, LLC 15,000$18,0000.00%
Amplius Wealth Advisors, LLC 10,000$11,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 55,599$63,0000.00%
View complete list of HEPION PHARMACEUTICALS INC shareholders